Daily News Podcast

MDedge Daily News: Which diabetes drug boosts survival best?

Publish date: April 18, 2018

 

Which diabetes drug boosts survival best? Community cancer clinics keep closing. A champion arises among oral anticoagulants. And there’s new promise in early-stage lung cancer.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

Hope and hype: Inside the push for wearable diabetes technology
MDedge Endocrinology
Sensitivity of vibration-based neuropathy detectors varies widely
MDedge Endocrinology
Being overweight as a child increases the risk of developing diabetes
MDedge Endocrinology
Clearer picture emerging of renal impact of SGLT2s
MDedge Endocrinology
Diabetes from checkpoint inhibitors probably means lifelong insulin
MDedge Endocrinology
Cardiovascular risk in type 2 diabetes: Patients are often clueless
MDedge Endocrinology
MDedge Daily News: Diabetes patients ignore a deadly risk
MDedge Endocrinology
FDA approves marketing for retinal imaging device that uses artificial intelligence
MDedge Endocrinology
VIDEO: Meta-analysis: Mortality, safety data may favor SGLT2 inhibitors in T2DM
MDedge Endocrinology
‘Fast food swamps’ linked to type 1 diabetes
MDedge Endocrinology